Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: Three case reports

M. Nishida; M. Nakamura

doi:10.1097/00004850-200401000-00008

Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: Three case reports

M. Nishida^*, M. Nakamura

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.

Original language	English
Pages (from-to)	41-43
Number of pages	3
Journal	International Clinical Psychopharmacology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1097/00004850-200401000-00008
Publication status	Published - 2004 Jan 1
Externally published	Yes

Keywords

Diabetes mellitus
Obesity
Perospirone
Schizophrenia

ASJC Scopus subject areas

Psychiatry and Mental health
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00004850-200401000-00008

Cite this

@article{756ff9d2ea3f4bc587c6f58c557b88a8,

title = "Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: Three case reports",

abstract = "We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.",

keywords = "Diabetes mellitus, Obesity, Perospirone, Schizophrenia",

author = "M. Nishida and M. Nakamura",

year = "2004",

month = jan,

day = "1",

doi = "10.1097/00004850-200401000-00008",

language = "English",

volume = "19",

pages = "41--43",

journal = "International Clinical Psychopharmacology",

issn = "0268-1315",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia

T2 - Three case reports

AU - Nishida, M.

AU - Nakamura, M.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.

AB - We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.

KW - Diabetes mellitus

KW - Obesity

KW - Perospirone

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=1642493870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642493870&partnerID=8YFLogxK

U2 - 10.1097/00004850-200401000-00008

DO - 10.1097/00004850-200401000-00008

M3 - Article

C2 - 15101570

AN - SCOPUS:1642493870

SN - 0268-1315

VL - 19

SP - 41

EP - 43

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

IS - 1

ER -

Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: Three case reports

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this